Análisis de las hospitalizaciones por enfermedad cardiovascular en población diabética en España

Zapatero-Gaviria, Antonio; Gómez‐Huelgas, Ricardo; Canora, Jesús; Ena-Muñoz, J.; Romero-Sánchez, M.; Méndez‐Bailón, Manuel; Marco-Martínez, Javier; Barba, Raquel

doi:10.1016/j.rce.2018.09.012

Cited by 10 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding epidemiological parameters, this review included 31 articles published between 2009 and 2019 that analysed the prevalence of CVD overall or a type of CVD in patients with T2DM in Spain [ 15 , 16 , 19 , 20 , 23 – 25 , 28 – 35 , 37 , 42 , 43 , 45 , 52 , 54 – 57 , 59 – 63 , 65 , 66 ], 20 articles that analysed incidence [ 15 , 21 – 23 , 27 , 36 , 38 – 41 , 44 , 46 , 48 – 51 , 53 , 56 , 58 , 64 ], and 18 articles that analysed mortality [ 16 , 18 , 21 , 22 , 25 , 27 , 30 , 31 , 38 – 41 , 44 , 46 , 56 , 57 , 60 , 66 ].…”

Section: Resultsmentioning

confidence: 99%

“…Table 2 summarizes the prevalence or frequency of CV comorbidities in the samples of patients with T2DM described in the articles. Seven studies analysed the overall prevalence of CVD at the national level [ 28 , 34 , 52 , 54 , 55 , 59 , 66 ]. A recent countrywide study analysed the prevalence of CVD in 619,188 patients with T2DM hospitalized in Spain in 2015 and is the largest study to date on this topic [ 66 ].…”

Section: Resultsmentioning

confidence: 99%

“…A recent countrywide study analysed the prevalence of CVD in 619,188 patients with T2DM hospitalized in Spain in 2015 and is the largest study to date on this topic [ 66 ].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Introduction: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in people with type 2 diabetes mellitus (T2DM). The objectives of this systematic literature review were to identify and synthesize published data describing the epidemiology and mortality of CVD in the T2DM population and the associated economic burden. Methods: We conducted a systematic review searching the PubMed and MEDES databases from 2009 to 2019 using predefined selection criteria. Peer-reviewed observational studies reporting primary or secondary data on CVD prevalence, incidence, mortality, resource use and costs in patients with T2DM in Spain, written in English and Spanish, were included. Data were tabulated and summarized descriptively. Results: Of 706 articles identified, 52 were included in the review. Most studies were based on data from hospital discharge databases and registries. The reported prevalence of CVD among patients with T2DM ranged from 6.9 to 40.8%. The prevalence of coronary heart disease ranged from 4.7 to 37%, stroke from 3.5 to 19.6%, peripheral artery disease from 2.5 to 13.0%, and heart failure from 4.3 to 20.1%. Inhospital CVD mortality rates ranged from 5.6 to 10.8%. Direct costs due to CVD in hospitalized patients with T2DM were increased ([ 50%) compared with patients without CVD. No studies analysed indirect costs of CVD in patients with T2DM. Conclusions: The burden of CVD among patients with T2DM, combined with the elevated costs of care, highlights the importance of early prevention as part of integrated management of the disease to improve clinical and economic outcomes.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…5 6 8 9 26 The most prevalent CV event in hospitalized patients with T2DM is congestive heart failure (20.1%), followed by cerebrovascular disease (10.3%), coronary disease (9.4%) and peripheral arterial disease (9.1%). 5 However, very few studies have evaluated the economic implications of CV events in patients with T2DM treated in the Spanish hospital setting. 27 We have only identified internationally based studies that specifically examine the economic impact associated with clinical outcomes based on the MACE variable.…”

Section: Significance Of This Studymentioning

confidence: 99%

“…2 In Spain, 7.8% of the adult population are diagnosed with T2DM 3 and about 23.2% of these have CVD, 4 with this figure reaching 40.8% in hospitalized patients with T2DM. 5…”

Section: Introductionmentioning

confidence: 99%

Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015

Artola¹,

García-Moll

Uría

et al. 2020

BMJ Open Diab Res Care

View full text Add to dashboard Cite

IntroductionCardiovascular (CV) disease affects a high percentage of patients with type 2 diabetes mellitus (T2DM), especially in the hospital setting, impacting on mortality, complications, quality of life and use of health resources. The aim of this study was to estimate the incidence, mean length of hospital stay (LOHS) and costs attributable to hospital admissions due to CV events in patients with T2DM versus patients without diabetes mellitus (non-DM) in Spain.Research design and methodsRetrospective observational study based on the Spanish National Hospital Discharge Database for 2015. Hospital admissions for patients aged ≥35 years with a diagnosis of CV death, non-fatal acute myocardial infarction (AMI), non-fatal stroke, unstable angina, heart failure and revascularization were evaluated. The International Classification of Diseases, Ninth Revision (250.x0 or 250.x2) coding was used to classify records of patients with T2DM. For each CV complication, the hospital discharges of the two groups, T2DM and non-DM, were precisely matched and the number of hospital discharges, patients, LOHS and mean cost were quantified. Additional analyses assessed the robustness of the results.ResultsOf the 276 925 hospital discharges analyzed, 34.71% corresponded to patients with T2DM. A higher incidence was observed in all the CV complications studied in the T2DM population, with a relative risk exceeding 2 in all cases. The mean LOHS (days) was longer in the T2DM versus the non-DM group for: non-fatal AMI (7.63 vs 7.02, p<0.001), unstable angina (5.11 vs 4.78, p=0.009) and revascularization (7.96 vs 7.57, p<0.001). The mean cost per hospital discharge was higher in the T2DM versus the non-DM group for non-fatal AMI (€6891 vs €6876, p=0.029) and unstable angina (€3386 vs €3304, p<0.001).ConclusionsPatients with T2DM had a higher incidence and number of hospital admissions per patient due to CV events versus the non-DM population. This generates a significant clinical and economic burden given the longer admission stay and higher costs associated with some of these complications.

show abstract

Analysis of hospitalizations in the population with diabetes with EHRead tools

Barajas-Galindo

Maza

Cano-Rodríguez

et al. 2021

Endocrinología, Diabetes y Nutrición (English ed.)

View full text Add to dashboard Cite

Análisis de las hospitalizaciones por enfermedad cardiovascular en población diabética en España

Cited by 10 publications

References 22 publications

Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review

Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review

Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015

Analysis of hospitalizations in the population with diabetes with EHRead tools

Contact Info

Product

Resources

About